Savara, Inc. (SVRA)
4.74
-0.02
(-0.42%)
USD |
NASDAQ |
Oct 15, 16:00
4.755
+0.02
(+0.32%)
After-Hours: 20:00
Savara Cash from Operations (TTM) : -110.38M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -110.38M |
| March 31, 2026 | -106.89M |
| December 31, 2025 | -101.04M |
| September 30, 2025 | -99.26M |
| June 30, 2025 | -99.40M |
| March 31, 2025 | -95.63M |
| December 31, 2024 | -89.09M |
| September 30, 2024 | -81.41M |
| June 30, 2024 | -71.90M |
| March 31, 2024 | -59.68M |
| December 31, 2023 | -51.06M |
| September 30, 2023 | -44.11M |
| June 30, 2023 | -39.11M |
| March 31, 2023 | -38.16M |
| December 31, 2022 | -34.55M |
| September 30, 2022 | -35.27M |
| June 30, 2022 | -36.03M |
| March 31, 2022 | -38.91M |
| December 31, 2021 | -40.08M |
| September 30, 2021 | -43.02M |
| June 30, 2021 | -40.80M |
| March 31, 2021 | -36.35M |
| December 31, 2020 | -39.84M |
| September 30, 2020 | -37.48M |
| June 30, 2020 | -42.19M |
| Date | Value |
|---|---|
| March 31, 2020 | -47.34M |
| December 31, 2019 | -45.12M |
| September 30, 2019 | -45.67M |
| June 30, 2019 | -43.02M |
| March 31, 2019 | -40.46M |
| December 31, 2018 | -39.28M |
| September 30, 2018 | -38.25M |
| June 30, 2018 | -37.74M |
| March 31, 2018 | -35.06M |
| December 31, 2017 | -28.23M |
| September 30, 2017 | -20.95M |
| June 30, 2017 | -15.57M |
| March 31, 2017 | 0.114M |
| December 31, 2016 | -8.37M |
| September 30, 2016 | -14.99M |
| June 30, 2016 | -20.38M |
| March 31, 2016 | -36.93M |
| December 31, 2015 | -32.95M |
| September 30, 2015 | -30.15M |
| June 30, 2015 | -27.26M |
| March 31, 2015 | -25.72M |
| December 31, 2014 | -24.64M |
| September 30, 2014 | -23.49M |
| June 30, 2014 | -21.89M |
| March 31, 2014 | -19.57M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Gilead Sciences, Inc. | 13.55B |
| Insmed, Inc. | -778.92M |
| United Therapeutics Corp. | 1.682B |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| ACADIA Pharmaceuticals, Inc. | 160.32M |